Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signaling.
Endometriosis, a leading cause of pelvic pain and infertility, is characterized by ectopic growth of endometrial-like tissue and affects approximately 176 million women worldwide. The pathophysiology involves inflammatory and angiogenic mediators as well as estrogen-mediated signaling and novel, imp...
Guardado en:
Autores principales: | Rajesh Kumar, Anne-Catherine Clerc, Ilaria Gori, Ronan Russell, Chiara Pellegrini, Lerisa Govender, Jean-Christophe Wyss, Dela Golshayan, Geraldine O Canny |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/38800685721149aeb2a7655c6cd80daa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lipoxins: nature's way to resolve inflammation
por: Chandrasekharan JA, et al.
Publicado: (2015) -
Functional analyses of endometriosis-related polymorphisms in the estrogen synthesis and metabolism-related genes.
por: Hsin-Shih Wang, et al.
Publicado: (2012) -
Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis
por: Xinxin Liu, et al.
Publicado: (2017) - Prostaglandins
-
Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis.
por: Linda Vong, et al.
Publicado: (2012)